Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
2.330
+0.030 (1.30%)
At close: Aug 13, 2025, 4:00 PM
2.246
-0.084 (-3.59%)
Pre-market: Aug 14, 2025, 9:04 AM EDT
Immix Biopharma Market Cap
Immix Biopharma has a market cap or net worth of $67.18 million as of August 14, 2025. Its market cap has increased by 20.54% in one year.
Market Cap
67.18M
Enterprise Value
56.59M
1-Year Change
20.54%
Ranking
Category
Stock Price
$2.33
Market Cap Chart
Since the IPO on December 16, 2021, Immix Biopharma's market cap has increased from $65.74M to $67.18M, an increase of 2.19%. That is a compound annual growth rate of 0.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 67.18M | 11.02% |
| Dec 31, 2024 | 60.52M | -55.98% |
| Dec 29, 2023 | 137.48M | 331.07% |
| Dec 30, 2022 | 31.89M | -32.18% |
| Dec 31, 2021 | 47.02M | -28.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |